encorafenib,binimetinib
pierre fabre,ono pharma,pfizer
['binimetinib', 'encorafenib', 'nsclc', 'sclc']
pleased to present these new data at asco #asco23 and simultaneous publication in jco. here, we tested combination of encorafenib + binimetinib in patients metastatic braf v600e mutant nsclc 1/ 
Medical Oncologist in NYC. Clinical focus on lung cancer and thymic malignancies. COI: https://t.co/HSKHhXqXbM…